![]() |
市場調査レポート
商品コード
1541088
質量分析の市場レポート:技術、用途、地域別、2024~2032年Mass Spectrometry Market Report by Technology (Triple Quadrupole, Quadrupole TOF, FTMS, Quadrupole, Time-of-Flight, ION Trap, and Others), Application, and Region 2024-2032 |
||||||
カスタマイズ可能
|
質量分析の市場レポート:技術、用途、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2~3営業日
|
世界の質量分析の市場規模は2023年に65億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに112億米ドルに達し、2024~2032年の間に6%の成長率(CAGR)を示すと予測しています。最近の技術動向、品質管理のための厳格な規制政策の賦課、個別化医療への注目の高まり、官民両部門における研究開発(R&D)資金の急増などが、市場を後押しする主要要因の一部です。
質量分析とは、イオンの質量電荷比を測定するために使用される分析技術を指します。ガスクロマトグラフ質量分析法(GC-MS)、マトリックス支援レーザー脱離イオン化法(MALDI)、液体クロマトグラフ質量分析法(LC-MS)などがあります。質量分析には、高感度、特異性、広いダイナミックレンジなど多くの特徴があります。創薬、環境モニタリング、科学捜査、食品安全、臨床診断、プロテオミクス、石油探査、材料科学などで広く利用されています。質量分析は、高性能能力、分析の多様性、多次元分析のための他の技術との互換性を記載しています。
官民両部門で研究開発(R&D)資金が増加し、先進的な質量分析システムの導入に財政的な支援を行っていることが、市場の成長を後押ししています。さらに、大気や水質サンプルの分析が必要となる環境汚染に対する懸念の高まりも成長を促す要因となっています。さらに、犯罪捜査における物質分析の緊急要件と相まって、法医学の拡大が高まっていることも市場成長に寄与しています。このほか、生体サンプル中の代謝物を詳細に分析するメタボロミクスのセグメントが急成長していることも、市場の成長を後押ししています。これとは別に、さまざまな科学的探求のための学術研究における質量分析の採用が、市場成長の触媒となっています。さらに、質量分析がクロマトグラフィーのような他の技術と統合され、その適用範囲が拡大している技術的収束が、市場の成長を強化しています。
最近の技術的進歩
技術進歩の急増が質量分析の市場の拡大に大きく寄与しています。高感度、高精度、高速スループットといった最先端の改良により、これらの機器は現代の検査室に欠かせないものとなっています。さらに、技術の進歩は質量分析装置の能力を拡大し、ますます複雑なサンプルの分析にも対応できるようになっています。さらに、高分解能質量分析計やタンデム質量分析計など、これまでにないレベルの詳細さと分析深度を提供する最近の技術革新が市場の成長を支えています。さらに、即時のデータ収集と解釈を可能にするリアルタイムモニタリング機能の搭載が、市場の成長を強化しています。さらに、質量分析装置の小型化により、現場での分析に使用できるポータブルユニットが開発されていることも、市場の成長を後押ししています。
品質管理に対する厳格な規制政策の導入
医薬品や食品安全などの産業における品質管理に対する規制要件が、質量分析の市場の成長を後押ししています。規制機関による厳格な基準の採用より、企業は不純物の検出、製品の品質の確保、プロセスの検証において高い精度と感度を持つ質量分析に依存するようになっています。さらに、質量分析では、化合物が純度基準を満たしていること、汚染物質が極めて低い濃度で検出されることが保証されます。さらに、農薬や毒素、その他の汚染物質が含まれていないことを確認するために食品産業でこの技術が広く利用されていることも、市場の成長を後押ししています。さらに、このような規制上の義務により、質量分析は単なるオプションではなく、製品開発や製造プロセスにおける品質保証のために必要不可欠なものとなっています。
個別化医療への注目の高まり
個別化医療への注目が高まっていることも、質量分析の市場を刺激する極めて重要な要因です。医療はますます個々の患者に合わせてカスタマイズされるようになっており、その結果、詳細な分子と遺伝子情報の需要が高まっています。質量分析計は、バイオマーカー、代謝物、タンパク質を分子レベルで分析できるため、プロテオミクスやゲノミクス研究において重要な役割を果たします。これら洞察は、個人の健康プロファイルを理解し、疾患感受性を予測し、それに応じて治療を調整するために極めて重要です。さらに、個別化医療の台頭により、医療プロバイダーや研究機関は、正確で患者に特化したデータの需要に対応するため、質量分析技術への投資を進めています。その結果、個別化医療への注目は、既存市場での質量分析の応用を後押ししているだけでなく、医療の新たなセグメントへの参入を開拓しています。
The global mass spectrometry market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. The recent technological advancements, imposition of strict regulatory policies for quality control, growing focus on personalized medicine, and escalating funding for research and development (R&D) in both public and private sector are some of the major factors propelling the market.
Mass spectrometry refers to an analytical technique used to measure the mass-to-charge ratio of ions. It includes gas chromatography-mass spectrometry (GC-MS), matrix-assisted laser desorption/ionization (MALDI), and liquid chromatography-mass spectrometry (LC-MS). Mass spectrometry offers numerous features, such as high sensitivity, specificity, and a broad dynamic range. It is widely used in drug discovery, environmental monitoring, forensics, food safety, clinical diagnostics, proteomics, petroleum exploration, and materials science. Mass spectrometry offers high-throughput capabilities, versatility in analysis, and compatibility with other techniques for multidimensional analysis.
The escalating funding for research and development (R&D) in both public and private sectors, which is providing financial support for acquiring advanced mass spectrometry systems is propelling the market growth. Additionally, the growing concerns about environmental pollution that are necessitating the analysis of air and water samples are acting as another growth-inducing factor. Furthermore, the rising expansion of forensic science, coupled with the urgent requirement for substance analysis in criminal investigations, is contributing to the market growth. Besides this, the burgeoning field of metabolomics, which involves the detailed analysis of metabolites in biological samples, is bolstering the market growth. Apart from this, the adoption of mass spectrometry in academic research for various scientific explorations is catalyzing the market growth. Moreover, technological convergence, where mass spectrometry is being integrated with other techniques like chromatography, thus expanding its applicability, is strengthening the market growth.
The recent technological advancements
The surge in technological advancements is significantly contributing to the expansion of the mass spectrometry market. Cutting-edge improvements, such as higher sensitivity, better accuracy, and rapid throughput are making these instruments indispensable in modern laboratories. Furthermore, technological progress is expanding the capabilities of mass spectrometry instruments to include the analysis of increasingly complex samples. Additionally, recent innovations like high-resolution mass spectrometry and tandem mass spectrometry that are providing unprecedented levels of detail and analytical depth are supporting the market growth. Moreover, the incorporation of real-time monitoring capabilities, allowing immediate data collection and interpretation, is strengthening the market growth. In addition, the miniaturization of mass spectrometry devices, leading to the creation of portable units that can be employed for on-site analysis, is favoring the market growth.
The imposition of strict regulatory policies for quality control
Regulatory requirements for quality control in industries, such as pharmaceuticals and food safety are propelling the mass spectrometry market growth. The introduction of stringent standards by regulatory agencies is prompting companies to rely on mass spectrometry for its high degree of accuracy and sensitivity in detecting impurities, ensuring product quality, and validating processes. In addition, mass spectrometry ensures that compounds meet purity standards and that contaminants are detected at extremely low concentrations. Furthermore, the widespread technology utilization in the food industry to ensure the absence of pesticides, toxins, and other contaminants is favoring the market growth. Moreover, these regulatory compulsions make mass spectrometry not just an option but a necessity for quality assurance in product development and manufacturing processes.
The growing focus on personalized medicine
The growing emphasis on personalized medicine is another pivotal factor stimulating the mass spectrometry market. Healthcare is becoming increasingly tailored to individual patients, resulting in a higher demand for detailed molecular and genetic information. Mass spectrometry provides the capability to analyze biomarkers, metabolites, and proteins at a molecular level, thereby playing a significant role in proteomics and genomics research. These insights are crucial for understanding individual health profiles, predicting disease susceptibility, and tailoring treatments accordingly. Furthermore, the rise in personalized medicine is pushing healthcare providers and research institutions to invest in mass spectrometry technologies to keep up with the demand for precise, patient-specific data. As a result, the focus on personalized healthcare is not only boosting the application of mass spectrometry in existing markets but is also pioneering its entry into new avenues of medical science.
IMARC Group provides an analysis of the key trends in each segment of the global mass spectrometry market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on technology and application.
Triple Quadrupole (Tandem)
Quadrupole TOF (Q-TOF)
FTMS (Fourier Transform Mass Spectrometry)
Quadrupole
Time-of-Flight (TOF)
ION Trap
Others
Triple quadrupole (tandem) dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes triple quadrupole (Tandem), quadrupole TOF (Q-TOF), FTMS (fourier transform mass spectrometry), quadrupole, time-of-flight (TOF), ION trap, and others. According to the report, triple quadrupole (tandem) represented the largest segment.
Triple quadrupole systems offer high sensitivity and selectivity, making them ideal for detecting low-abundance analytes in complex samples. Furthermore, they are versatile and can be applied to various fields, such as proteomics, metabolomics, pharmaceuticals, and environmental analysis. This multi-disciplinary application range contributes to their widespread adoption. Besides this, triple quadrupole mass spectrometers excel in quantitative measurements, as they provide excellent repeatability and accuracy, which are crucial in sectors like drug development and diagnostics. Additionally, these systems are often compatible with various ionization techniques and chromatography systems, allowing for broader applications and easier integration into existing workflows. Moreover, triple quadrupole meets or exceeds the stringent regulations and quality standards required in many industries, which makes them a safer investment for compliance-conscious organizations.
Pharmaceuticals
Biotechnology
Chemical and Petrochemicals
Environmental Testing
Food & Beverage Testing
Others
Pharmaceutical hold the largest share in the market
A detailed breakup and analysis of the market based on application has also been provided in the report. This includes pharmaceuticals, biotechnology, chemical and petrochemicals, environmental testing, food & beverage testing, and others. According to the report, pharmaceuticals represented the largest segment.
Pharmaceuticals are dominating the market as it is governed by strict regulatory standards. In line with this, mass spectrometry is invaluable for quality control and compliance, ensuring that pharmaceutical products meet these rigorous benchmarks. Furthermore, mass spectrometry is critical in the various stages of drug discovery, including target identification, screening, and pharmacokinetics. It provides accurate and precise data that aid researchers in the identification and quantification of compounds, thereby accelerating the time-to-market for new drugs. Besides this, mass spectrometry offers the high sensitivity and specificity required for proteomic and genomic studies, thereby driving its adoption in the pharmaceutical sector. Additionally, it is extensively used in metabolomics to identify and quantify metabolites, thus offering valuable insights into drug metabolism. Moreover, mass spectrometry is routinely used for quality control and batch-to-batch verification of raw materials, intermediates, and finished products.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest mass spectrometry market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America hosts some of the world's leading research institutions and laboratories, which contributes to a high demand for mass spectrometry equipment for advanced research. Additionally, various government agencies are offering substantial grants and funding options for research and development (R&D) activities, including those that require mass spectrometry, thus fostering a favorable environment for market growth. Besides this, North America is the headquarters for numerous companies that are market leaders in the mass spectrometry segment. Moreover, the region is at the forefront of technological innovation in advanced mass spectrometry techniques like time-of-flight (TOF) and orbitrap. In addition to this, the presence of a robust healthcare system, coupled with the focus on precision medicine and diagnostics in the region, is further boosting the market growth.
Top companies are developing new technologies and improving existing mass spectrometry techniques. This includes creating instruments that are faster, more sensitive, and easier to use. Furthermore, they are engaging in acquisitions and mergers to diversify their portfolio, enter into new markets, and strengthen their presence. Apart from this, leading players are partnering with research institutions, laboratories, or other firms to share expertise and resources, which enables them to bring products to market more quickly and to tackle problems from multiple angles. Besides this, companies are also working to ensure that their products meet strict regulatory standards, both locally and globally. It involves clinical trials, rigorous testing, and obtaining necessary certifications. Moreover, major players are offering robust customer service, including training programs to educate users on how to get the most out of their mass spectrometry equipment.
Agilent Technologies Inc.
Bruker
Danaher Corporation
JEOL Ltd.
Kore Technology Ltd.
LECO Corporation
PerkinElmer Inc.
Rigaku Corporation
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Waters Corporation
In June 2022, Agilent Technologies Inc. announced the launch of new quadrupole mass spectrometers at the ASMS conference on mass spectrometry and allied topics.
In June 2023, Bruker launched the timsTOF ultra mass spectrometer with transformative sensitivity.
In February 2021, JEOL announced the launch of new time-of-flight mass spectrometers with improved performance and functionality.